Skip to main content
Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
554.38
-3.00 (-0.54%)
Oct 25, 2024, 4:00 PM EDT - Market closed

Thermo Fisher Revenue by Segment
Period Ending Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017
Laboratory Products Revenue
22.94B 22.93B 23.00B 23.04B 23.27B 23.13B 22.83B 22.51B
Laboratory Products Revenue Growth
-1.41% -0.86% 0.74% 2.35% 12.09% 23.93% 36.66% 51.47%
Life Sciences Solutions Revenue
9.50B 9.54B 9.65B 9.98B 10.55B 11.08B 11.91B 13.53B
Life Sciences Solutions Revenue Growth
-10.02% -13.90% -18.99% -26.27% -27.89% -28.00% -23.93% -13.43%
Analytical Instruments Revenue
7.31B 7.26B 7.23B 7.26B 7.10B 6.97B 6.83B 6.62B
Analytical Instruments Revenue Growth
2.96% 4.15% 5.83% 9.65% 9.78% 10.20% 10.15% 9.14%
Speciality Diagnostics Revenue
4.46B 4.41B 4.41B 4.41B 4.42B 4.40B 4.39B 4.76B
Speciality Diagnostics Revenue Growth
1.02% 0.39% 0.39% -7.52% -13.35% -18.45% -20.58% -15.83%
Eliminations Revenue
-1.84B -1.80B -1.79B -1.83B -1.92B -2.05B -2.16B -2.51B

Operating Income by Segment
Period Ending Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017
Life Sciences Solutions Operating Income
3.45B 3.47B 3.42B 3.42B 3.57B 3.73B 4.24B 5.58B
Life Sciences Solutions Operating Income Growth
-3.37% -6.97% -19.28% -38.73% -45.50% -49.04% -45.01% -28.59%
Laboratory Products Operating Income
3.07B 3.23B 3.31B 3.36B 3.39B 3.18B 3.05B 2.87B
Laboratory Products Operating Income Growth
-9.56% 1.64% 8.67% 16.92% 34.52% 45.91% 57.53% 55.75%
Analytical Instruments Operating Income
1.88B 1.89B 1.89B 1.91B 1.80B 1.72B 1.63B 1.51B
Analytical Instruments Operating Income Growth
4.45% 10.44% 15.98% 26.61% 27.27% 32.95% 32.71% 25.90%
Speciality Diagnostics Operating Income
1.15B 1.14B 1.14B 1.12B 1.07B 1.01B 951.00M 1.02B
Speciality Diagnostics Operating Income Growth
7.68% 13.43% 19.66% 9.77% -4.04% -16.46% -21.08% -20.00%

Operating Expense Breakdown
Period Ending Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017
Selling, General, and Administrative
6.83B 6.67B 6.65B 6.57B 6.73B 6.90B 6.97B 7.13B
Selling, General, and Administrative Growth
1.43% -3.33% -4.47% -7.83% -7.12% -4.63% -2.00% 4.17%
Amortization of Intangibles
2.08B 2.21B 2.28B 2.34B 2.37B 2.38B 2.39B 2.40B
Amortization of Intangibles Growth
-12.25% -6.98% -4.56% -2.38% 4.32% 13.30% 22.86% 36.00%
Research and Development
1.34B 1.32B 1.32B 1.34B 1.40B 1.43B 1.45B 1.47B
Research and Development Growth
-4.14% -8.16% -9.02% -9.11% -4.82% -2.65% 0.21% 4.62%
Restructuring and Other
231.00M 270.00M 376.00M 459.00M 434.00M 383.00M 224.00M 114.00M
Restructuring and Other Growth
-46.77% -29.50% 67.86% 302.63% 313.33% 325.56% 21.08% -42.13%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.